A citation-based method for searching scientific literature

Boris P Kovatchev. Nat Rev Endocrinol 2017
Times Cited: 89







List of co-cited articles
514 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome.
Hironori Takahashi, Noriaki Iwahashi, Jin Kirigaya, Shunsuke Kataoka, Yugo Minamimoto, Masaomi Gohbara, Takeru Abe, Kozo Okada, Yasushi Matsuzawa, Masaaki Konishi,[...]. Cardiovasc Diabetol 2018
25
16

Time in range: a new parameter to evaluate blood glucose control in patients with diabetes.
Monica Andrade Lima Gabbay, Melanie Rodacki, Luis Eduardo Calliari, Andre Gustavo Daher Vianna, Marcio Krakauer, Mauro Scharf Pinto, Janice Sepúlveda Reis, Marcia Puñales, Leonardo Garcia Miranda, Ana Claudia Ramalho,[...]. Diabetol Metab Syndr 2020
10
40

The Development of New Composite Metrics for the Comprehensive Analytic and Visual Assessment of Hypoglycemia Using the Hypo-Triad.
Andreas Thomas, John Shin, Boyi Jiang, Chantal McMahon, Ralf Kolassa, Robert A Vigersky. J Diabetes Sci Technol 2018
6
50

Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture.
A Risso, F Mercuri, L Quagliaro, G Damante, A Ceriello. Am J Physiol Endocrinol Metab 2001
255
3

The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles.
Andreas Thomas, Martin Schönauer, Frank Achermann, Oliver Schnell, Markolf Hanefeld, Hans-Jürgen Ziegelasch, John Mastrototaro, Lutz Heinemann. Diabetes Technol Ther 2009
26
11


Factors influencing inter-day glycemic variability in diabetic outpatients receiving insulin therapy.
Hiroko Mori, Yosuke Okada, Akira Kurozumi, Manabu Narisawa, Yoshiya Tanaka. J Diabetes Investig 2017
14
21

Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes.
Anders L Carlson, Deborah M Mullen, Richard M Bergenstal. Diabetes Technol Ther 2017
54
5

Measurements of glucose control.
F J Service, P C O'Brien, R A Rizza. Diabetes Care 1987
93
3



Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy.
L Monnier, C Colette, S Dejager, D R Owens. Rev Endocr Metab Disord 2016
15
20

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.
Allen B King, Athena Philis-Tsimikas, Eric S Kilpatrick, Irene H Langbakke, Kamilla Begtrup, Tina Vilsbøll. Diabetes Technol Ther 2017
12
25


The UVA/PADOVA Type 1 Diabetes Simulator: New Features.
Chiara Dalla Man, Francesco Micheletto, Dayu Lv, Marc Breton, Boris Kovatchev, Claudio Cobelli. J Diabetes Sci Technol 2014
123
3

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
3

Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement.
S Borot, P Y Benhamou, C Atlan, E Bismuth, E Bonnemaison, B Catargi, G Charpentier, A Farret, N Filhol, S Franc,[...]. Diabetes Metab 2018
22
13


Approved IFCC reference method for the measurement of HbA1c in human blood.
Jan-Olof Jeppsson, Uwe Kobold, John Barr, Andreas Finke, Wieland Hoelzel, Tadao Hoshino, Kor Miedema, Andrea Mosca, Pierluigi Mauri, Rita Paroni,[...]. Clin Chem Lab Med 2002
331
3

Glucose variability aggravates cardiac fibrosis by altering AKT signalling path.
Changjiang Ying, Ting Liu, Hongwei Ling, Mingyue Cheng, Xiaoyan Zhou, Shanshan Wang, Yizhen Mao, Lei Chen, Runze Zhang, Wei Li. Diab Vasc Dis Res 2017
18
16

Effects of blood glucose rate of changes on perceived mood and cognitive symptoms in insulin-treated type 2 diabetes.
Daniel J Cox, Anthony McCall, Boris Kovatchev, Samiha Sarwat, Liza L Ilag, Meng H Tan. Diabetes Care 2007
19
15

The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes.
Alexandra K Lee, Bethany Warren, Clare J Lee, John W McEvoy, Kunihiro Matsushita, Elbert S Huang, A Richey Sharrett, Josef Coresh, Elizabeth Selvin. Diabetes Care 2018
65
4

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.
David M Maahs, Bruce A Buckingham, Jessica R Castle, Ali Cinar, Edward R Damiano, Eyal Dassau, J Hans DeVries, Francis J Doyle, Steven C Griffen, Ahmad Haidar,[...]. Diabetes Care 2016
95
3

How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?
Silvio E Inzucchi, Guillermo Umpierrez, Andres DiGenio, Rong Zhou, Boris Kovatchev. Diabetes Res Clin Pract 2015
5
60


A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin.
Hiroshi Nomoto, Hideaki Miyoshi, Hajime Sugawara, Kota Ono, Shingo Yanagiya, Mayuko Oita, Akinobu Nakamura, Tatsuya Atsumi. Diabetol Metab Syndr 2017
16
18

Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou, Changsheng Ma. Cardiovasc Diabetol 2011
146
3


Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction.
Gong Su, Shu-hua Mi, Hong Tao, Zhao Li, Hong-Xia Yang, Hong Zheng, Yun Zhou, Lei Tian. Diabetes Care 2013
79
3


Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
Anxin Wang, Xiaoxue Liu, Jie Xu, Xiaochen Han, Zhaoping Su, Shuohua Chen, Nan Zhang, Shouling Wu, Yongjun Wang, Yilong Wang. J Am Heart Assoc 2017
25
12


Variability of fasting plasma glucose increased risks of diabetic polyneuropathy in T2DM.
Chun-Pai Yang, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Kai-Lin Hwang, Sing-Yu Yang, Tsai-Chung Li, Cheng-Chieh Lin. Neurology 2017
15
20

The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Ji Eun Jun, Sang-Man Jin, Jongha Baek, Sewon Oh, Kyu Yeon Hur, Myung-Shik Lee, Moon-Kyu Lee, Jae Hyeon Kim. Cardiovasc Diabetol 2015
53
5

Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.
Martin Tauschmann, Janet M Allen, Malgorzata E Wilinska, Hood Thabit, Zoë Stewart, Peiyao Cheng, Craig Kollman, Carlo L Acerini, David B Dunger, Roman Hovorka. Diabetes Care 2016
66
4


Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes.
Marc D Breton, Sue A Brown, Colleen Hughes Karvetski, Laura Kollar, Katarina A Topchyan, Stacey M Anderson, Boris P Kovatchev. Diabetes Technol Ther 2014
64
4

Diabetes: Models, Signals, and Control.
Claudio Cobelli, Chiara Dalla Man, Giovanni Sparacino, Lalo Magni, Giuseppe De Nicolao, Boris P Kovatchev. IEEE Rev Biomed Eng 2009
151
3

Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas.
Boris P Kovatchev, Eric Renard, Claudio Cobelli, Howard C Zisser, Patrick Keith-Hynes, Stacey M Anderson, Sue A Brown, Daniel R Chernavvsky, Marc D Breton, Anne Farret,[...]. Diabetes Care 2013
94
3

DiAs user interface: a patient-centric interface for mobile artificial pancreas systems.
Patrick Keith-Hynes, Stephanie Guerlain, Benton Mize, Colleen Hughes-Karvetski, Momin Khan, Molly McElwee-Malloy, Boris P Kovatchev. J Diabetes Sci Technol 2013
48
6


Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes.
Claudio Cobelli, Eric Renard, Boris P Kovatchev, Patrick Keith-Hynes, Najib Ben Brahim, Jérôme Place, Simone Del Favero, Marc Breton, Anne Farret, Daniela Bruttomesso,[...]. Diabetes Care 2012
68
4

The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes.
Boris Kovatchev, William V Tamborlane, William T Cefalu, Claudio Cobelli. Diabetes Care 2016
38
7

Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.
John M Lachin, Saul Genuth, David M Nathan, Bernard Zinman, Brandy N Rutledge. Diabetes 2008
254
3

Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.
Edmond A Ryan, Tami Shandro, Kristy Green, Breay W Paty, Peter A Senior, David Bigam, A M James Shapiro, Marie-Christine Vantyghem. Diabetes 2004
187
3


Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial.
Julio Rosenstock, Ronnie Aronson, George Grunberger, Markolf Hanefeld, PierMarco Piatti, Pierre Serusclat, Xi Cheng, Tianyue Zhou, Elisabeth Niemoeller, Elisabeth Souhami,[...]. Diabetes Care 2016
120
3

Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes.
Matthew Riddle, Guillermo Umpierrez, Andres DiGenio, Rong Zhou, Julio Rosenstock. Diabetes Care 2011
143
3


Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial.
Juan P Frías, Samer Nakhle, James A Ruggles, Sergey Zhuplatov, Eric Klein, Rong Zhou, Poul Strange. Diabetes Obes Metab 2017
16
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.